Quantcast
Home / DC News / Court rules Vioxx securities suit timely filed

Court rules Vioxx securities suit timely filed

A claim by investors that Merck & Co. misrepresented the heart attack risk posed by the drug Vioxx was not time-barred because it was filed within two years of the discovery of the violation, and Merck did not show that a reasonably diligent plaintiff would have discovered it sooner, the U.S. Supreme Court has ruled.